1477815-93-2

Upstream product

• 177276-41-4 4-(piperazin-1-yl)piperidine-1-carboxylic acid tert-butyl ester 
• 177276-40-3 4-(1-tert-butoxycarbonylpiperidin-4-yl)piperazine-1-carboxylic acid benzyl ester 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 1477815-41-0 4-[4-(4-bromo-3-trifluoromethoxyphenylcarbamoyl)piperazin-1-yl]piperidine-1-carboxylic acid tert-butyl ester 

Downstream Products

• 1477815-94-3 4-[1-(3-hydroxy-2,2-dimethylpropionyl)piperidin-4-yl]piperazine-1-carboxylic acid(4-bromo-3-trifluoromethoxyphenyl)amide 
• 1477815-91-0 4-[1-(2,2-dimethylpropionyl)piperidin-4-yl]piperazine-1-carboxylic acid(4-bromo-3-trifluoromethoxyphenyl)amide 

Relevant academic research and scientific papers

PIPERAZINE-PIPERIDINE COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS

The invention provides compounds of formula (I): wherein the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are inhibitors of replication of the hepatitis C virus. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat hepatitis C viral infections, and processes and intermediates useful for preparing such compounds.